These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17322886)

  • 1. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes.
    Felix NJ; Donermeyer DL; Horvath S; Walters JJ; Gross ML; Suri A; Allen PM
    Nat Immunol; 2007 Apr; 8(4):388-97. PubMed ID: 17322886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How the T cell repertoire becomes peptide and MHC specific.
    Huseby ES; White J; Crawford F; Vass T; Becker D; Pinilla C; Marrack P; Kappler JW
    Cell; 2005 Jul; 122(2):247-60. PubMed ID: 16051149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells.
    Michaëlsson E; Broddefalk J; Engström A; Kihlberg J; Holmdahl R
    Eur J Immunol; 1996 Aug; 26(8):1906-10. PubMed ID: 8765038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular basis of allorecognition of major histocompatibility complex molecules by T lymphocytes.
    Lombardi G; Lechler R
    Ann Ist Super Sanita; 1991; 27(1):7-14. PubMed ID: 1958030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-specific oligomerization of T-cell receptor molecules.
    Reich Z; Boniface JJ; Lyons DS; Borochov N; Wachtel EJ; Davis MM
    Nature; 1997 Jun; 387(6633):617-20. PubMed ID: 9177351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell tolerance is influenced by concomitant T cell recognition of cross-reactive self-peptides.
    Tam RC; Fedoseyeva EV; Moskalenko M; Garovoy MR; Benichou G
    J Immunol; 1996 May; 156(10):3765-71. PubMed ID: 8621912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activation of pigeon cytochrome c-specific T cell hybridomas by antigenic peptides is influenced by non-native sequences at the amino terminus of the determinant.
    Bhayani H; Carbone FR; Paterson Y
    J Immunol; 1988 Jul; 141(2):377-82. PubMed ID: 2454990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-immune response relationships of hapten-modified collagen II peptides in a T-cell model of allergic contact dermatitis.
    Holmdahl M; Ahlfors SR; Holmdahl R; Hansson C
    Chem Res Toxicol; 2008 Aug; 21(8):1514-23. PubMed ID: 18616296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an I-Ed-restricted T-cell epitope of Escherichia coli outer membrane protein F.
    Williams KM; Bigley EC
    Infect Immun; 2004 Jul; 72(7):3907-13. PubMed ID: 15213134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactive CD8+ T cells can recognize unusual, rare, and unique processed peptide/MHC complexes.
    Malarkannan S; Gonzalez F; Nguyen V; Adair G; Shastri N
    J Immunol; 1996 Nov; 157(10):4464-73. PubMed ID: 8906823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preformed purified peptide/major histocompatibility class I complexes are potent stimulators of class I-restricted T cell hybridomas.
    Stryhn A; Pedersen LO; Ortiz-Navarrete V; Buus S
    Eur J Immunol; 1994 Jun; 24(6):1404-9. PubMed ID: 8206101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
    de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes.
    Plaksin D; Polakova K; McPhie P; Margulies DH
    J Immunol; 1997 Mar; 158(5):2218-27. PubMed ID: 9036968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping immune responses to mRBP-3 1-16 peptide with altered peptide ligands.
    Guyver CJ; Copland DA; Calder CJ; Sette A; Sidney J; Dick AD; Nicholson LB
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2027-35. PubMed ID: 16639012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of peptide interaction with MHC creates TCR partial agonists.
    Ryan KR; McNeil LK; Dao C; Jensen PE; Evavold BD
    Cell Immunol; 2004 Jan; 227(1):70-8. PubMed ID: 15051516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct orientation of the alloreactive monoclonal CD8 T cell activation program by three different peptide/MHC complexes.
    Auphan-Anezin N; Mazza C; Guimezanes A; Barrett-Wilt GA; Montero-Julian F; Roussel A; Hunt DF; Malissen B; Schmitt-Verhulst AM
    Eur J Immunol; 2006 Jul; 36(7):1856-66. PubMed ID: 16761314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity.
    Krogsgaard M; Li QJ; Sumen C; Huppa JB; Huse M; Davis MM
    Nature; 2005 Mar; 434(7030):238-43. PubMed ID: 15724150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural characteristics of an antigen required for its interaction with Ia and recognition by T cells.
    Sette A; Buus S; Colon S; Smith JA; Miles C; Grey HM
    Nature; 1987 Jul 30-Aug 5; 328(6129):395-9. PubMed ID: 3497349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER-2 peptides p776 and F7, N-terminal-linked with Ii-Key tetramer (LRMK) help the proliferation of E75-TCR+ cells: The dependency of help on the side chains of LRMK-extended peptide pointed towards the T cell receptor.
    Li Y; Ishiyama S; Matsueda S; Tsuda N; Ioannides CG
    Oncol Rep; 2008 Jun; 19(6):1445-52. PubMed ID: 18497949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.